• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

WatchPAT™ Spearheads Breakthrough of At-Home Testing

February 16, 2011 by admin

New CPT release along with pricing any day between now and 31 October.

• In October 2010, the American Medical Association to announce a new CPT (Current Procedural Terminology) code for at-home testing of obstructive sleep apnea (OSA), which will go into effect January 1, 2011.
• Home testing and diagnosing of OSA will now become uniformly reimbursable for all physicians.
• Home testing with the WatchPAT (wrist-worn device and finger-mounted probe) delivers diagnostic accuracy at a fraction of the cost of sleep lab testing, significantly lowering the cost of health care.
• Several key studies indicate that patients with undiagnosed and untreated OSA utilize health care resources almost two-fold higher—with heavier use of resources seen in women.
• Outpatient testing for sleep-related breathing disorders using a wrist-worn device and finger-mounted probe was selected as one of the Top 10 Medical Innovations for 2010 by a panel of experts at the world-renowned Cleveland Clinic.

It is estimated that over 28 million Americans suffer from obstructive sleep apnea (OSA), with approximately 20 million more going undiagnosed and untreated. The health-related cost burden for undiagnosed OSA in the United States—a dangerous condition that can lead to a variety of heart ailments, stroke, and death—is estimated at $3.4 billion.

The latest figures compiled by Frost & Sullivan in 2008 show revenues in the U.S. sleep apnea diagnostic and therapeutic market totaling approximately $1.35 billion, with a 16.2% growth rate.

WatchPAT, produced by medical device manufacturer Itamar-Medical, Ltd., is the industry leader for at-home OSA testing. WatchPAT is approved, available for all physicians as a diagnostic tool, and is poised to continue market domination once the CPT (Current Procedural Terminology) code for at-home diagnosis goes into effect January 1, 2011.

“With the new CPT code going into effect, millions of Americans suffering from sleep apnea can now benefit from easy, low cost access to in-home sleep testing using our WatchPAT device,” notes Dr. Dov Rubin, President and CEO of Itamar-Medical. “Patients can now take the test in the comfort of their own bed, affording them timely diagnosis and treatment for sleep apnea, which is linked to other ailments such as heart disease, hypertension, and obesity.”

Rubin also adds, “Internists, cardiologists, and family physicians can now order the tests and get reimbursed. Using Itamar-Medical’s WatchPORTAL technology, physicians can download the information instantaneously at no extra charge and obtain a diagnosis in consultation with a local sleep physician or via Itamar’s nationwide network of experts, with results wirelessly delivered back to a smartphone.”

WatchPAT sleep tests outnumber the nearest competitor by 5:1, making it by far the most used at-home sleep apnea testing device of its kind. While sleep lab PSG (polysomnography) testing has been the standard of care for OSA diagnosis, it is anticipated that many labs will also be offering home testing in order to expand their services. In a July 2010 Wells Fargo Securities survey of national sleep centers, analysts reported that 21% of sleep centers currently offer home sleep testing for Medicare patients and 23% offer home testing for privately insured patients, both 20% jumps from a previous survey.

Additionally, another 29% of sleep centers plan to offer home tests in the next six months, a 19% increase since their previous survey. Moreover, 38% of the respondents indicated that they plan to increase involvement in home testing, up from 32% from the prior survey.

According to Dr. Steven Lamm, a New York internist who regularly performs WatchPAT tests on his patients, “With WatchPAT and the new CPT code, we now have the technology that will allow community doctors nationwide easy access to diagnosing sleep apnea. Because of that, the role of the sleep lab will change. Sleep lab testing is still extremely important, though I want to reserve it for those patients with especially complicated sleep issues, such as restless legs syndrome, insomnia, and narcolepsy.”

Source: Itamar-Medical Ltd

Filed Under: Blog Tagged With: apnea, cardiologists, care, community, condition, diagnosis, Disease, effect, Health, Home, Home Sleep, Home Sleep Testing, Home Testing, insomnia, Medical, obesity, Outpatient, restless legs syndrome, Sleep, sleep apnea, sleep center, Sleep Centers, Sleep Lab, sleep test, sleep testing, Technology, Treatment

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy